3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 2,767 | 4,008 |
受取手形及び売掛金 | 2,100 | 1,804 |
電子記録債権 | 531 | 464 |
商品及び製品 | 2,193 | 2,112 |
仕掛品 | 621 | 442 |
原材料及び貯蔵品 | 726 | 776 |
その他 | 108 | 114 |
貸倒引当金 | △3 | △3 |
流動資産合計 | 9,045 | 9,721 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 501 | 663 |
機械装置及び運搬具(純額) | 371 | 675 |
土地 | 636 | 694 |
建設仮勘定 | 111 | 1,166 |
その他(純額) | 127 | 170 |
有形固定資産合計 | 1,748 | 3,370 |
無形固定資産 | | |
リース資産 | 130 | 99 |
その他 | 13 | 17 |
無形固定資産合計 | 143 | 116 |
投資その他の資産 | | |
投資有価証券 | 1,520 | 1,809 |
繰延税金資産 | 109 | 221 |
その他 | 78 | 68 |
投資その他の資産合計 | 1,708 | 2,099 |
固定資産合計 | 3,600 | 5,587 |
資産合計 | 12,646 | 15,308 |
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
負債の部 | | |
流動負債 | | |
買掛金 | 1,418 | 1,450 |
電子記録債務 | - | 83 |
1年内返済予定の長期借入金 | - | 100 |
未払法人税等 | 66 | 204 |
賞与引当金 | 136 | 230 |
その他 | 568 | 826 |
流動負債合計 | 2,190 | 2,895 |
固定負債 | | |
長期借入金 | - | 716 |
退職給付に係る負債 | - | 124 |
繰延税金負債 | 135 | 255 |
その他 | 14 | 13 |
固定負債合計 | 150 | 1,110 |
負債合計 | 2,340 | 4,006 |
純資産の部 | | |
株主資本 | | |
資本金 | 300 | 300 |
資本剰余金 | 3,453 | 3,438 |
利益剰余金 | 6,513 | 7,213 |
自己株式 | △377 | △327 |
株主資本合計 | 9,888 | 10,624 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 403 | 646 |
繰延ヘッジ損益 | - | △0 |
為替換算調整勘定 | 12 | 30 |
その他の包括利益累計額合計 | 416 | 676 |
非支配株主持分 | - | 0 |
純資産合計 | 10,305 | 11,301 |
負債純資産合計 | 12,646 | 15,308 |
E3676943600株式会社マナック・ケミカル・パートナーズMANAC Chemical Partners Co.,Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse436002026-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002026-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002026-03-31jpcrp_cor:ReconcilingItemsMember436002025-04-012026-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-04-012026-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002025-04-012026-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember436002025-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002025-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002025-03-31jpcrp_cor:ReconcilingItemsMember436002026-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002025-03-31jppfs_cor:RetainedEarningsMember436002025-03-31jppfs_cor:CapitalSurplusMember436002025-03-31jppfs_cor:CapitalStockMember436002026-05-14436002026-03-31436002025-04-012026-03-31436002025-03-31436002024-04-012025-03-31436002024-03-31436002024-03-31jppfs_cor:ShareholdersEquityMember436002024-03-31jppfs_cor:CapitalStockMember436002024-03-31jppfs_cor:CapitalSurplusMember436002024-03-31jppfs_cor:RetainedEarningsMember436002024-03-31jppfs_cor:TreasuryStockMember436002024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002024-04-012025-03-31jppfs_cor:ShareholdersEquityMember436002024-04-012025-03-31jppfs_cor:CapitalStockMember436002024-04-012025-03-31jppfs_cor:CapitalSurplusMember436002024-04-012025-03-31jppfs_cor:RetainedEarningsMember436002024-04-012025-03-31jppfs_cor:TreasuryStockMember436002024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002024-04-012025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember436002026-03-31jpcrp_cor:ReportableSegmentsMember436002025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember436002025-03-31jpcrp_cor:ReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:FineChemicalBusinessReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:FlameRetardantsBusinessReportableSegmentsMember436002024-04-012025-03-31tse-acedjpfr-43600:HealthSupportBusinessReportableSegmentsMember436002024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember436002026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002026-03-31jppfs_cor:ShareholdersEquityMember436002026-03-31jppfs_cor:TreasuryStockMember436002026-03-31jppfs_cor:RetainedEarningsMember436002026-03-31jppfs_cor:CapitalSurplusMember436002026-03-31jppfs_cor:CapitalStockMember436002025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002025-04-012026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002025-04-012026-03-31jppfs_cor:ShareholdersEquityMember436002025-04-012026-03-31jppfs_cor:TreasuryStockMember436002025-04-012026-03-31jppfs_cor:RetainedEarningsMember436002025-04-012026-03-31jppfs_cor:CapitalSurplusMember436002025-04-012026-03-31jppfs_cor:CapitalStockMember436002025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember436002025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember436002025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember436002025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember436002025-03-31jppfs_cor:ShareholdersEquityMember436002025-03-31jppfs_cor:TreasuryStockMember436002026-03-31jppfs_cor:NonControllingInterestsMember436002025-04-012026-03-31jppfs_cor:NonControllingInterestsMember436002025-03-31jppfs_cor:NonControllingInterestsMemberiso4217:JPYxbrli:pure